Rafarma announces consolidation of financial reports in preparation for PCAOB-Registrant Audit
Rafarma Pharmaceuticals (OTC: RAFA), which previously announced plans for a full audit and a streamlining of its corporate structure,...
Rafarma announces consolidation of financial reports in preparation for PCAOB-Registrant Audit
Rafarma announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure
Rafarma Pharmaceuticals, Inc. enters new distribution agreement with Amber Pharma Distribution Group
Rafarma Pharmaceuticals enter $50,000,000 Ceftriaxone market
Rafarma Pharmaceuticals registers CEFTRIAXONE under international label
Rafarma Pharmaceuticals, Inc. receives general license for pharmaceutical products
Rafarma Pharmaceuticals, Inc. named 1 of 4 national strategic pharmaceutical suppliers to the Russia
Rafarma receives new symbol and launches social media campaign
Rafarma Pharmaceuticals, Inc. achieves full certification